Loading chat...
ND HB1543
Bill
Status
3/26/2025
Primary Sponsor
Lisa Meier
Click for details
AI Summary
-
Legislative management shall study prescription drug pricing and federal maximum fair price determinations during the 2025-26 interim
-
Study must examine federal drug price negotiations under the Inflation Reduction Act of 2022 and identify overlap with drugs covered by the public employees retirement system
-
Required input from the public employees retirement system, insurance commissioner, state board of pharmacy, and other stakeholders
-
Findings, recommendations, and any implementing legislation must be reported to the 70th Legislative Assembly
-
Passed House 89-4 and Senate 44-1
Legislative Description
AN ACT to provide for a legislative management study regarding prescription drug pricing and the maximum fair price as determined by the federal government.
Last Action
Filed with Secretary Of State 03/26
3/27/2025